First Mercantile Trust’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-12,132
Closed -$330K 879
2019
Q4
$330K Sell
12,132
-790
-6% -$21.5K 0.04% 310
2019
Q3
$370K Sell
12,922
-440
-3% -$12.6K 0.04% 302
2019
Q2
$371K Buy
13,362
+3,109
+30% +$86.3K 0.04% 269
2019
Q1
$340K Sell
10,253
-439
-4% -$14.6K 0.08% 295
2018
Q4
$311K Sell
10,692
-764
-7% -$22.2K 0.08% 301
2018
Q3
$527K Sell
11,456
-552
-5% -$25.4K 0.1% 240
2018
Q2
$449K Sell
12,008
-553
-4% -$20.7K 0.09% 273
2018
Q1
$371K Buy
12,561
+6,060
+93% +$179K 0.08% 318
2017
Q4
$223K Sell
6,501
-1,067
-14% -$36.6K 0.04% 505
2017
Q3
$274K Sell
7,568
-125
-2% -$4.53K 0.05% 471
2017
Q2
$199K Sell
7,693
-2,235
-23% -$57.8K 0.04% 568
2017
Q1
$191K Sell
9,928
-1,012
-9% -$19.5K 0.03% 589
2016
Q4
$182K Sell
10,940
-6,947
-39% -$116K 0.03% 607
2016
Q3
$368K Buy
17,887
+2,593
+17% +$53.3K 0.05% 455
2016
Q2
$468K Sell
15,294
-94
-0.6% -$2.88K 0.06% 404
2016
Q1
$576K Sell
15,388
-1,535
-9% -$57.5K 0.07% 343
2015
Q4
$730K Sell
16,923
-3,702
-18% -$160K 0.07% 325
2015
Q3
$772K Buy
20,625
+476
+2% +$17.8K 0.08% 325
2015
Q2
$684K Sell
20,149
-5,285
-21% -$179K 0.06% 402
2015
Q1
$900K Buy
25,434
+4,594
+22% +$163K 0.07% 343
2014
Q4
$710K Sell
20,840
-756
-4% -$25.8K 0.06% 407
2014
Q3
$833K Sell
21,596
-4,734
-18% -$183K 0.07% 383
2014
Q2
$1.03M Buy
26,330
+4,270
+19% +$166K 0.08% 334
2014
Q1
$754K Sell
22,060
-3,045
-12% -$104K 0.05% 472
2013
Q4
$527K Sell
25,105
-1,765
-7% -$37.1K 0.04% 551
2013
Q3
$631K Sell
26,870
-11,675
-30% -$274K 0.05% 509
2013
Q2
$1.04M Buy
+38,545
New +$1.04M 0.09% 324